The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I’m interested that you say it’s easy to recycle. From what I understand there{s virtually no recycling at the moment and although this might be a matter of limitted resources as most batteries are relatively new, they{re a nightmare to handle, regularly causing serious fires at waste menegment facilities as they can spontaneously combust, so there is a reasonable incentive to recycle them, along with the rapidly increasing price of lithium, the rapidly increasing waste resource and all the other environmental benefits of using recycled vs. raw materials. I{m not saying you{re wrong, but I{d be very interested to see some examples of lithium battery recycling. I agree it will have to happen, or we{ve got a serious problem on our hands. Although this wouldn{t be the first time the environmental lobby has closed it{s eyes to the inevitable problems of a change they{ve demanded.
All sounds very iffy to my pretty untrained mind. The story they've been spinning would produce plenty of cash flow to expand organically if they really had the interests of shareholders at heart. I've been overexposed here for some time, think it's time to re-balance. Just wish I had confidence in anything else to reinvest. Cash is a one way bet at the moment with central governments acting no better than corrupt CEO's. Maybe it's time to just spend it all. Hoorah. GLA.
Eagerly awaiting the thoughts of those with more expertise than I on the results. To my untrained eye they look very good, particularly happy with the dividend, although in the light of current prices we perhaps remain over-valued.
Difficult to find much cheer in those figures. I was hoping someone here would find something to grasp on to. Looks like it’ll be a bloodbath.
Well thanks for the reply. There was some useful content in it. I don't understand the need for abuse, I'm perfectly relaxed thanks. It's a public board, anyone can post what they like, the more they do the better. Have you tried meditation?
Well I don{t know where you reside, but not many operational managers are assassinated with 20 high calibre bullets through their windscreen because the local population disagrees with company policy where I live.
I read with sadness the serious security problems Rio Tinto have had at their Richards Bay mine in South Africa, forcing them to cease operations. Specifically the General Operations manager was shot dead last month. The security situation in South Africa is notoriously bad, but it{s difficult to really understand it from boring old blighty. I{m now heavily invested in companies operating out of South Africa and I have to say that story is making me consider at least reducing my exposure. If anyone has any nuance on this issue I{d be very interested. Thanks.
Thanks, it's an argument. We only need to have the balance of probabilities on our side. Still surprising there aren't more buyers if it's so undervalued. It's not hard to buy as many shares as you want.
TBTT, on what basis do you think there's a seller holding the price back? The trading volume for THS looks to me to be quite a lot lower than SLP and JLP. If there were as many buyers for THS the seller could easily unload, but it appears not to be the case. I appreciate it did seem to happen on the last big jump, but that makes no argument for it to be happening again.
I was just about to post something similar on the SLP board, but guess here's the appropriate place to vent. My largest holding by a long way is still SLP, but I've been increasing my THS and JLP holdings substantially recently having been burned being overweight in CEY last year and finding myself even more overweight SLP this year. It's certainly churlish to complain when it's sitting near all time highs, but I wish I'd stuck with SLP so far. I can't understand why it isn't reacting to the PGM prices like SLP and JLP. I guess it's the growth trajectory of SLP favouring the management of SLP over THS. Making similar profit from much smaller base is a pretty good recommendation. But it's getting increasingly difficult to justify, it's tempting to rebalance, but SLP just keeps out performing. I guess diversifying inevitably means something will underperform relatively, another investment psychological barrier to overcome. I should be happy they're all doing well. Wish I'd stuck it all into Ethereum now as well of course.
Palladium just smashed through $3,000 like a champagne bottle on the Titanic. Hmm, never was much good with metaphors.
Thanks for the replies. In my understanding the article was referring to the viability of all northern Portuguese deposits, which would include Minas de Borosso, but it could easily be a journalist trying to make a story or a geologist with a chip on his shoulder and local friends in the protest movement. Savannah clearly refer to Spodumene, and as others have said, apart from that there's a lot of positive comments about SAV. I guess it just confirms what we all know, that this sort of investment is very high risk.
Sorry, article here: https://www.politico.eu/article/portugal-lithium-mining-project-scrap/
Thanks for the heads up. There's an interesting article about it here, with a good bit about Savannah as well. On Savannah, they have a Geologist who says Mina De Borroso is a Lithium Petalite deposit, which is much harder to process than Lithium Spodumene. On their website Savannah clearly state they are mining Lithium Spodumene. Does anyone have any more information about the deposit at Mina de Borroso?
Thanks TBTT. Makes sense. Wish I was as clever as this ‘Market’ guy. Does he give tips?
Strange not to see any movement over at SLP and JLP.
I was just going to ask the same thing. I guess it’s just a technical issue in an exchange.
Given we're vaccinating healthy people with something with a 60% efficacy, a treatment with 30% efficacy would look like a very good option to me. I sold out earlier in the year, and I'm far from a medical expert, but I'm back in much deeper, it's starting to look like a very good story. An effective treatment has solo many advantages over vaccines - not to mention lockdowns - I'm as excited personally as much as financially.
It’s by far my biggest holding for what that’s worth. Followed by JLP. It’s worked out very well so far. There are just too many arguments supporting each of the PGM’s for mé to take any profits yet. I’m personally most bullish about Platinum and it’s plaice in Hydrogen production, which seems at least very likely to become a very important párt of the push to renewables. I’m not altogether cónvinced it’s a sensible path to take, but there’s little doubt we’re taking it. The Rhodium boom is a nice bonus for my purposes. I Hope and anticipate they will become worthwhile dividend stocks. Of course the sorts of rises we’ve had and the political climate in South Africa make mé nervous as well. Risks are certainly easier to take when you’re already well ahead.